AbbVie, GSK Announce Refunds for 340B Overcharges

AbbVie and GSK announced they will refund 340B providers for certain medications following ceiling price recalculations.
Drugmakers AbbVie and GlaxoSmithKline (GSK) will refund 340B providers for some products following ceiling price recalculations, according to notices posted [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Post Election Analysis: Implications for the 340B Program

Ted Slafsky, publisher and CEO of 340B Report, writes a column on the impact of the recent elections on the 340B program.
With President-elect Donald Trump’s (R) big victory and the GOP takeover of the U.S. Senate in last week’s elections, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Returns to Power: How the 2024 Election Outcomes Could Affect the 340B Program

Former President Donald Trump's (R) victory in Tuesday’s presidential election could have significant implications for the 340B program.
Former President Donald Trump’s victory over Democratic Vice President Kamala Harris in Tuesday’s presidential election capped a series of high-profile [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Hears Arguments Over DSH Calculations That Could Result in More Hospitals Qualifying for 340B

The U.S. Supreme Court recently heard arguments in a case challenging a federal rule over disproportionate share hospital calculations and payments.
The U.S. Supreme Court heard arguments Tuesday on a case challenging a federal rule over disproportionate share hospital (DSH) calculations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program

Voters will cast ballots in Tuesday's presidential contest between Vice President Kamala Harris (D) and former President Donald Trump (R).
When voters across the U.S. cast their ballots in Tuesday’s elections, they will not just be deciding who will control [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eli Lilly Announces Refunds for 340B Overcharges

Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices.
Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Appeals Court Ruling That Blocked DSH Calculation Changes That Impact 340B Eligibility

The 5th Circuit Court of Appeals will take up a case that Texas hospitals filed against HHS to block changes to how the Medicare DSH payment calculation is determined.
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ascend, Xellia Announce Refunds for 340B Overcharges

Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations.
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Organon To Extend Contract Pharmacy Restrictions to CHCs on Dec. 1

Organon announced that, effective Dec. 1, it will extend its contract pharmacy restrictions to HRSA-funded health centers.
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live